CN102499366A - 调节血脂和抗疲劳的保健食品 - Google Patents
调节血脂和抗疲劳的保健食品 Download PDFInfo
- Publication number
- CN102499366A CN102499366A CN2011103435995A CN201110343599A CN102499366A CN 102499366 A CN102499366 A CN 102499366A CN 2011103435995 A CN2011103435995 A CN 2011103435995A CN 201110343599 A CN201110343599 A CN 201110343599A CN 102499366 A CN102499366 A CN 102499366A
- Authority
- CN
- China
- Prior art keywords
- blood fat
- health
- royal jelly
- fat
- antifatigue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 33
- 239000008280 blood Substances 0.000 title claims abstract description 33
- 235000013305 food Nutrition 0.000 title abstract description 5
- 229940109850 royal jelly Drugs 0.000 claims abstract description 21
- 244000194101 Ginkgo biloba Species 0.000 claims abstract description 19
- 239000007901 soft capsule Substances 0.000 claims abstract description 15
- 235000020710 ginseng extract Nutrition 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 239000000463 material Substances 0.000 claims abstract description 5
- 230000002929 anti-fatigue Effects 0.000 claims description 17
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 16
- 239000000843 powder Substances 0.000 claims description 11
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 10
- 235000013402 health food Nutrition 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 7
- 230000001105 regulatory effect Effects 0.000 claims description 7
- 229930003427 Vitamin E Natural products 0.000 claims description 5
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 5
- 235000019165 vitamin E Nutrition 0.000 claims description 5
- 229940046009 vitamin E Drugs 0.000 claims description 5
- 239000011709 vitamin E Substances 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 4
- 244000068988 Glycine max Species 0.000 claims description 3
- 235000010469 Glycine max Nutrition 0.000 claims description 3
- 240000008415 Lactuca sativa Species 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 3
- 235000012045 salad Nutrition 0.000 claims description 3
- 235000013871 bee wax Nutrition 0.000 claims description 2
- 239000012166 beeswax Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 13
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 4
- 238000002360 preparation method Methods 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 238000012795 verification Methods 0.000 abstract 1
- 235000019197 fats Nutrition 0.000 description 28
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 9
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 201000005577 familial hyperlipidemia Diseases 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 5
- 235000011201 Ginkgo Nutrition 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 239000002253 acid Substances 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000001934 delay Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- RSWGJHLUYNHPMX-UHFFFAOYSA-N 1,4a-dimethyl-7-propan-2-yl-2,3,4,4b,5,6,10,10a-octahydrophenanthrene-1-carboxylic acid Chemical compound C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- HVAUUPRFYPCOCA-AREMUKBSSA-N 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCOC[C@@H](OC(C)=O)COP([O-])(=O)OCC[N+](C)(C)C HVAUUPRFYPCOCA-AREMUKBSSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 229910001369 Brass Inorganic materials 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010020590 Hypercalciuria Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 108010003541 Platelet Activating Factor Proteins 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000002402 anti-lipaemic effect Effects 0.000 description 1
- 230000003005 anti-senility effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000000923 atherogenic effect Effects 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000010951 brass Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000036996 cardiovascular health Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000004098 cellular respiration Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 125000004073 flavone group Chemical group 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 235000020686 ginkgo biloba extract Nutrition 0.000 description 1
- 229940068052 ginkgo biloba extract Drugs 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- PWAOOJDMFUQOKB-WCZZMFLVSA-N ginsenoside Re Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]3C(C)(C)[C@@H](O)CC[C@]3(C)[C@@H]3[C@@]([C@@]4(CC[C@@H]([C@H]4[C@H](O)C3)[C@](C)(CCC=C(C)C)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C)(C)C2)O[C@H](CO)[C@@H](O)[C@@H]1O PWAOOJDMFUQOKB-WCZZMFLVSA-N 0.000 description 1
- AOGZLQUEBLOQCI-UHFFFAOYSA-N ginsenoside-Re Natural products CC1OC(OCC2OC(OC3CC4(C)C(CC(O)C5C(CCC45C)C(C)(CCC=C(C)C)OC6OC(CO)C(O)C(O)C6O)C7(C)CCC(O)C(C)(C)C37)C(O)C(O)C2O)C(O)C(O)C1O AOGZLQUEBLOQCI-UHFFFAOYSA-N 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- -1 lipid peroxide Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 235000021081 unsaturated fats Nutrition 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Jellies, Jams, And Syrups (AREA)
Abstract
本发明涉及一种对心血管有益的保健食品,即一种调节血脂和抗疲劳的保健食品。其有效成分由以下重量份数的原料制成:蜂王浆冻干粉2-4份,人参提取物1份,银杏叶提取物1-1.5份。以蜂王浆为主要原料,配合人参皂甙与银杏叶提取物,协同蜂王浆降血脂,抗疲劳的作用,使功能更为显著。选用合适的辅料,制得软胶囊制剂,经检验,产生了理想的调节血脂和抗疲劳功效。
Description
技术领域
本发明涉及一种对心血管有益的保健食品,即一种调节血脂和抗疲劳的保健食品。商品名称:金马牌欣脂宁软胶囊。
背景技术
在现有技术中,“心血管”是人体的生命之河,随着生活水平的不断提高,人们饮食结构也逐渐提升,人们血脂的“河床”颇无奈地抬高。据调查显示,高血脂已成为中老年人的常见病,并且越来越多的年轻人因为饮食的不节制,运动的减少,也加入到了高血脂的行列中,高血脂是引发各种心脑血管病的祸首,直接威肋人们的生命。高血脂症是指血中的胆固醇、甘油三脂、磷脂和末脂化的脂酸等血脂成分增高的一种病症,是动脉粥样硬化、高血压、冠心病、糖尿病的危险因素。血脂过高的人,还易衰老,易疲劳。不过,血脂高也并不可怕,只要合理的饮食、生活习惯的调整及服用适量保健食品,即可将血脂降下来。如今利于心血管保健效果的保健产品种类繁多,疗效各异。
发明内容
本发明的目的是针对上述不足而提供一种降血脂,抗疲劳保健效果显著的一种调节血脂和抗疲劳的保健食品。
本发明的技术解决方案是:一种调节血脂和抗疲劳的保健食品它由有效成分和常用的赋形剂或辅料制成,其有效成分由以下重量份数的原料制成:蜂王浆冻干粉2-4份,人参提取物1份,银杏叶提取物1-1.5份。优选蜂王浆冻干粉3份,人参提取物1份,银杏叶提取物1份。剂型不限于此,按上述各原料与常用的载体,如赋形剂或辅料可以混合制成片剂、胶囊剂、软胶囊剂、颗粒剂、散剂、丸剂、口服液、液体制剂或其它常规制剂。蜂王浆冻干粉符合农业部O/TSH03-2003标准(附录A),人参提取物符合农业部O/TSH03-2003标准(附录B)(人参皂甙含量≥大于等于80%),银杏叶提取物符合农业部O/TSH03-2003标准(附录C),(银杏叶总黄铜≥24%)。蜂王浆冻干粉、人参提取物、银杏叶提取物、维生素E油市面均可以直接购买。
蜂王浆自古就被人们视为滋补上品,科学家称其为世界唯一的可供人类服用的纯天然胎儿级食品,对人类有极强的营养保健功能和医疗作用。现代营养学和医学研究表明:蜂王浆具有增强机体免疫功能、延缓衰老、防癌抗癌、降血糖、降血脂、抗疲劳等保健功能。它的主要化学成分有蛋白质,氨基酸,矿物质,糖类等,并含有多种生物活成分,如SOD、酶与激素等。主要功能有调节血糖,血脂,延缓衰老,提高免疫,抗疲劳等。动物实验和临床研究证实,蜂王浆是降低胆固醇,防止动脉硬化的天然补剂。对于高血脂症单用药物治疗,效果不佳,应该进行综合治疗,在综合治疗措施中,食用蜂王浆对防治高血脂症表现出良好的效果。口服蜂王浆冻干粉胶囊,可明显降低甘油三、血清胆固醇,提高血液中高密度脂蛋白的浓度,降低低密度脂蛋白的浓度。60例临床观察,服用蜂王浆胶囊1-3个月,有效地治愈了高血脂症。另外蜂王浆有明显的抗疲劳作用,可使小鼠在不同温度中游泳的时间延长30-40%。
人参是强壮的滋补佳品,早在《神农本草经》中就有记载,并列为上品,具有补脾益肺,生沣安神的功能。主要成分为人参皂甙,具有多种生理作用。可以兴奋中枢、增强机体抵抗力、降压、降脂、抗疲劳等。人参提取物小鼠饲喂实验表明,其抗疲劳、耐缺氧能力明显提高。临床用于治疗高血症。给患者每日服用人参提取物,3个月后,血中胆固醇、三酰甘油、过氧化脂质显著下降,高密度脂蛋白升高,动脉硬化指数下降。
银杏被称为活化石,银杏叶具有敛肺止咳,活血止痛的功能。《本草纲目》记载“其性味甘苦而涩,入肺、肾二经,有定喘止咳,止带浊、缩小便”之功效。近年来银杏叶提取物由于其保健作用在国内外都倍受青睐。其主要成分有黄酮类、萜类,即银杏黄酮与银杏内脂。主要的药理作用为:拮抗血小板活化因子引起的血小板聚集,微血栓形成以及脂质代谢率乱。其中降血脂清除自由基作用明显。用高血脂饲料喂养SD大鼠,制备高血脂症大鼠模型,银杏叶黄酣每日灌胃,于给药14天和28天分别取血测定血清总胆固醇(TC)和甘油三脂(TG)指标,结果银杏叶黄酮组TC、TG水平明显降低。
维生素E:1、是一种强抗氧化剂,能有效地阻止食物和消化道内脂肪酸的酸败,保护细胞免受不饱和脂肪酸氧化产生的有害物质的伤害。2、是极好的自由基清除剂,能保护生物膜免受自由基攻击,有效的抗衰老营养素。3、提高肌体免疫力。4、保持血红细胞的完整性,促进血红细胞的生物合成。5、是细胞呼吸的必需促进因子,可保护肺组织免受空气污染。6、预肪心血管病。
工艺:蜂王浆冻干粉,充分干燥(含水量<5%),过120目;人参提取物,充分干燥(含水量<5%),过120目;银杏叶提取物,充分干燥(含水量<5%),过120目;按处方比例混合,将其与维生素E油混合均匀,与大豆色拉油混合,胶体磨研磨,过100目筛,压丸备用,制软胶囊,洗丸干燥,检验、包装。
产品成份含量:总黄酮0以芦丁计)≥555.8mg/100g,总皂甙0以人参皂甙Re计)≥2371mg/100g,10-羟基-2-葵烯酸≥895mg/100g。
保健功能:调节血脂、抗疲劳。
适宜人群:血脂偏高者、易疲劳者。
不适宜人群:少年儿童、孕期及哺乳期的妇女。
食用方法及食用量:每次900mg,每日2次。规格:900mg/粒、450mg/粒。
本发明的优点是:1、欣脂宁软胶囊以蜂王浆为主要原料,配合人参皂甙与银杏叶提取物,协同蜂王浆降血脂,抗疲劳的作用,使功能更为显著。2、选用合适的辅料,制得软胶囊制剂,经河南省卫生防疫站检验,产生了理想的调节血脂和抗疲劳功效。
下面将结合实施例对本发明的实施方式作进一步详细描述。
具体实施方式
实施例1
欣脂宁软胶囊由蜂王浆冻干粉135mg,人参提取物43.2mg,银杏叶提取物49.5mg,维生素E油1.8mg,大豆色拉油652.5mg,蜂蜡18mg制成。
实验例1
欣脂宁软胶囊经河南省卫生防疫站检验,结果表明:以不同剂量的金马牌欣脂宁软胶囊经口给予高脂模型大鼠喂饲30天,0.3g/kg,0.9g/kg两个剂量组的金马牌欣脂宁软胶龚能使大鼠血清中TC明显降低,0.15g/kg、0.3g/kg、0.9g/kg剂量组的金马牌欣脂宁软胶囊均能使大鼠血清中TG降低,结果表明在本试验条件下,金马牌欣脂宁软胶囊具有辅助降血脂的作用。
实验例2
欣脂宁软胶囊经河南省卫生防疫站检验,结果表明:在本试验条件下,经口连续给予小鼠不同剂量的金马牌欣脂宁软胶囊30天。各剂量组与溶剂对照组比较:300mg/kg、900mg/kg剂量组能延长小鼠负重游泳时间,降低运动时小鼠血清尿素氮的产生,增加小鼠肝糖原的含量。900mg/kg剂量组能降低小鼠运动后血乳酸的水平。结果表明金马牌欣脂宁软胶囊在本实验条件下具有缓解体力疲劳功能的作用。
Claims (4)
1.一种调节血脂和抗疲劳的保健食品,它由有效成分和常用的赋形剂或辅料制成,其特征在于有效成分由以下重量份数的原料制成:蜂王浆冻干粉2-4份,人参提取物1份,银杏叶提取物1-1.5份。
2.按照权利要求1所述的一种调节血脂和抗疲劳的保健食品,其特征在于蜂王浆冻干粉3份,人参提取物1份,银杏叶提取物1份。
3.按照权利要求1或2所述的一种调节血脂和抗疲劳的保健食品,其特征在于剂型为片剂、胶囊、颗粒剂、丸剂或口服液。
4.按照权利要求3所述的一种调节血脂和抗疲劳的保健食品,其特征在于由蜂王浆冻干粉135mg,人参提取物43.2mg,银杏叶提取物49.5mg,维生素E油1.8mg,大豆色拉油652.5mg,蜂蜡18mg制成软胶囊。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011103435995A CN102499366B (zh) | 2011-11-03 | 2011-11-03 | 调节血脂和抗疲劳的保健食品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011103435995A CN102499366B (zh) | 2011-11-03 | 2011-11-03 | 调节血脂和抗疲劳的保健食品 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102499366A true CN102499366A (zh) | 2012-06-20 |
CN102499366B CN102499366B (zh) | 2013-07-17 |
Family
ID=46211547
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011103435995A Expired - Fee Related CN102499366B (zh) | 2011-11-03 | 2011-11-03 | 调节血脂和抗疲劳的保健食品 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102499366B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102793176A (zh) * | 2012-09-06 | 2012-11-28 | 苏州谷力生物科技有限公司 | 一种具有缓解疲劳的保健品 |
CN102823799A (zh) * | 2012-09-24 | 2012-12-19 | 吉林省宏久生物科技股份有限公司 | 一种提高机体免疫力、补充维生素的保健食品 |
CN104415065A (zh) * | 2013-09-09 | 2015-03-18 | 石家庄维奥化工有限公司 | 一种治疗高脂血症的组合物 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101253984A (zh) * | 2008-03-20 | 2008-09-03 | 青岛大学医学院附属医院 | 蜂王浆银杏叶营养保健品及其制备方法 |
CN101637491A (zh) * | 2009-06-10 | 2010-02-03 | 北京一品堂医药科技有限公司 | 一种具有辅助降血糖、辅助降血脂功能的保健食品及其制备方法 |
CN101890060A (zh) * | 2010-07-09 | 2010-11-24 | 威海康宝生物科技开发有限公司 | 营养胰岛、降低血糖、调节血压血脂的制剂及其制备方法 |
CN102078383A (zh) * | 2010-12-31 | 2011-06-01 | 徐州银杏源生物工程有限公司 | 一种复方银杏叶胶囊、片剂配制方法 |
-
2011
- 2011-11-03 CN CN2011103435995A patent/CN102499366B/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101253984A (zh) * | 2008-03-20 | 2008-09-03 | 青岛大学医学院附属医院 | 蜂王浆银杏叶营养保健品及其制备方法 |
CN101637491A (zh) * | 2009-06-10 | 2010-02-03 | 北京一品堂医药科技有限公司 | 一种具有辅助降血糖、辅助降血脂功能的保健食品及其制备方法 |
CN101890060A (zh) * | 2010-07-09 | 2010-11-24 | 威海康宝生物科技开发有限公司 | 营养胰岛、降低血糖、调节血压血脂的制剂及其制备方法 |
CN102078383A (zh) * | 2010-12-31 | 2011-06-01 | 徐州银杏源生物工程有限公司 | 一种复方银杏叶胶囊、片剂配制方法 |
Non-Patent Citations (1)
Title |
---|
祝连彩等: "银杏叶提取物与人参皂苷对血管活性物质的影响", 《重庆大学学报(自然科学版)》, vol. 30, no. 4, 15 April 2007 (2007-04-15), pages 136 - 139 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102793176A (zh) * | 2012-09-06 | 2012-11-28 | 苏州谷力生物科技有限公司 | 一种具有缓解疲劳的保健品 |
CN102823799A (zh) * | 2012-09-24 | 2012-12-19 | 吉林省宏久生物科技股份有限公司 | 一种提高机体免疫力、补充维生素的保健食品 |
CN104415065A (zh) * | 2013-09-09 | 2015-03-18 | 石家庄维奥化工有限公司 | 一种治疗高脂血症的组合物 |
Also Published As
Publication number | Publication date |
---|---|
CN102499366B (zh) | 2013-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101878790B (zh) | 一种糖尿病专用强化营养面粉及其制备方法 | |
CN104026446B (zh) | 一种适合于高血糖人群服用的营养代餐粉及其制备方法 | |
CN102919836B (zh) | 一种降糖、降压、降脂、通便养颜、减肥、抗疲劳保健品及其生产工艺 | |
CN104643250B (zh) | 一种可双向调节体重改善亚健康的固体饮料 | |
CN106072573A (zh) | 一种适用于老年肌肉衰减症食用的特膳食品 | |
CN103238897A (zh) | 一种适用于糖尿病人的复合植物固体饮料 | |
CN106666312A (zh) | 一种辅助降血糖的保健食品及其颗粒剂和胶囊剂制备方法 | |
CN103099089A (zh) | 一种降糖、降压、通便减肥、抗疲劳、改善性功能保健品及其生产工艺 | |
CN102742837A (zh) | 一种用于改善营养不良症状的保健食品及其制备方法 | |
CN102599322A (zh) | 一种适合小儿的压片糖果及其制作方法 | |
CN106975069A (zh) | 一种保肝护肝组合物及其制备方法 | |
CN110327421A (zh) | 一种适合宇航员具有提高精力和协调人体各器官功能的组合物 | |
CN111771988A (zh) | 适用于糖尿病人食用的营养食品及其制备方法 | |
CN102499366B (zh) | 调节血脂和抗疲劳的保健食品 | |
CN101884783A (zh) | 一种含有麦麸多肽的抗疲劳中药及其制备方法 | |
CN108813501A (zh) | 具有清热润肺止咳化痰平喘和调节人体机能的养生蜂蜜膏 | |
KR20160141027A (ko) | 아위버섯 물 추출물을 유효성분으로 함유하는 대사성질환의 예방 및 치료용 약학적 조성물 또는 건강기능성식품 | |
CN102090637A (zh) | 一种含有胶原蛋白的复方营养粉 | |
CN101253984A (zh) | 蜂王浆银杏叶营养保健品及其制备方法 | |
CN104605352A (zh) | 用于促进人体血液循环、温补肾阳的玛卡和刺梨营养组合物,其制备方法和用途 | |
CN113925172A (zh) | 一种适用于儿童的大鲵肽营养组合物 | |
CN107412626A (zh) | 一种健脾祛湿组合物及其加工方法及在祛湿降尿酸产品中的应用 | |
CN109316565B (zh) | 一种降血脂组合物及其制备方法和应用 | |
CN1958035A (zh) | 用于降低血糖血脂和治疗糖尿病的药物组合物 | |
CN107136490A (zh) | 一种肽虫草保健品 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130717 |
|
CF01 | Termination of patent right due to non-payment of annual fee |